跳至主要内容
临床试验/NCT01941797
NCT01941797已完成不适用

Experimental Peri-implant Mucositis in Humans

UConn Health2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2012年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
2
主要终点
Gingival Crevicular fluid volume collected at baseline and weekly up to 9 weeks

研究概览

简要总结

This is a pilot study. The investigators hypothesize that the peri-implant soft tissue response to de novo plaque accumulation is similar to that of normal gingival tissue in the same subjects.

The investigators propose to conduct a controlled clinical trial to evaluate peri-implant soft tissue response to de novo plaque accumulation in comparison to the response of gingival tissue in the same subjects

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and Female ³21 years of age.
  • Oral site specific inclusion criteria:
  • Presence of 2 implants in the maxillary or mandibular arch supporting fixed restorations in function for at least 1 year (Test)
  • Presence of 2 teeth in the corresponding position of the implant (Control); -3) Absence of active infections at both test and control sites
  • Absence of radiographic bone loss at both test and control sites
  • Pocket depth ≤4mm at both test and control sites
  • must give written informed consent.

排除标准

  • Treatment with antibiotics for any dental or medical condition within 1 month before screening
  • Systemic diseases that require chronic use of anti-inflammatory medications, antibiotics or anticoagulants
  • Ongoing medications for systemic conditions initiated <3 months before the start of the study or the requirement to take prophylactic antibiotics for invasive dental procedures
  • Significant organ disease including impaired kidney function, heart murmur, rheumatic fever, bleeding disorder
  • Active infectious diseases such as hepatitis, tuberculosis and HIV
  • Clinically detectable caries and periodontal disease
  • Tobacco use of any kind
  • Use of medications affecting periodontal status (diphenylhydantoin, cyclosporine etc.)
  • No pregnancy or lactation or expectation to become pregnant within next 3 months.
  • Participants will be excluded from the study or analysis if any of the following occur during the study: 1) Changes in the patient medical status or medications that met the exclusion criteria; 2) Use of antimicrobial rinses; 3) Use of irrigating devices; 4) Subject noncompliance with stent wearing during the experimental mucositis/gingivitis phase and/or Vitamin C use; 5) Use of anti-inflammatory drugs or antibiotics; 6) allergic history to common toothpaste or mouth rinse ingredients.
  • Acute use of acetaminophen will be permitted.

结局指标

主要结局

Gingival Crevicular fluid volume collected at baseline and weekly up to 9 weeks

时间窗: 9 weeks

The gingival crevicular fluid ( GCF) volume is assessed using Periotron unit. The GCF volume is strongly correlated with peri-implant mucosa and gingival inflammation.

次要结局

未报告次要终点

研究者

发起方
UConn Health
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Experimental Peri-implant Mucositis in Humans | 临床试验